CD8 Minibody Repeatability Study

NCT05744128 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic decision

Conditions

Melanoma
Renal Cell Carcinoma

Interventions

BIOLOGICAL: Zirconium 89Zr crefmirlimab berdoxam

Sponsor

ImaginAb, Inc.

Collaborators

[object Object]